Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Dipharma“
Suchtreffer
Begriffe & Kennungen
Cegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Description of selected adverse reactions
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Hypersensitivity-type reactions, including skin rash, urticaria, angioedema, dyspnoea, erythaema, flushing, an
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Injection site reactions, including injection site erythaema (uncommon) as well as injection site pain (common
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Investigations Elevations in lactate dehydrogenase and alkaline phosphatase1; Transient elevations in LFT's fo
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Isolated cases of sickle cell crises have been reported in patients with sickle cell trait or sickle cell dise
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Nausea and headaches were very commonly observed in patients receiving chemotherapy.
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Paediatric population The experience in children is limited. A higher frequency of serious adverse reactions i
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical eff
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Splenic rupture including some fatal cases is uncommonly reported following administration of pegfilgrastim (s
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Splenomegaly, generally asymptomatic, is uncommon.
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Summary of the safety profile The most frequently reported adverse reactions were bone pain (very common [≥ 1/
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Tabulated list of adverse reactions The data in the table below describe adverse reactions reported from clini
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Uncommon cases of Sweet’s syndrome have been reported, although in some cases underlying haematological malign
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Uncommon elevations in liver function tests (LFTs) for ALT (alanine aminotransferase) or AST 8 (aspartate amin
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Uncommon events of cutaneous vasculitis have been reported in patients treated with pegfilgrastim. The mechani
Eintrag öffnenSapropterin Dipharma
Eintrag öffnenSapropterin Dipharma · 4.1 Therapeutic indications · 1
Eintrag öffnenSapropterin Dipharma · 4.1 Therapeutic indications · 2
Eintrag öffnenSapropterin Dipharma · 4.3 Contraindications · 1
Eintrag öffnen